Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, announced that it will report its second quarter 2019 financial results on Thursday, August 8, 2019.
SEATTLE and VANCOUVER, British Columbia, July 30, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will report its second quarter 2019 financial results on Thursday, August 8, 2019. Company management will host a conference call and live webcast at 4:30pm Eastern Time to provide an overview of financial results, the clinical development program, and a general corporate update.
To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 6587726. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.
Achieve Contact
Jason Wong
jwong@bplifescience.com
(415) 375-3340 ext. 4
View original content to download multimedia:http://www.prnewswire.com/news-releases/achieve-life-sciences-to-announce-second-quarter-2019-financial-results-and-host-conference-call-and-webcast-on-august-8-2019-300892687.html
SOURCE Achieve Life Sciences, Inc.
Company Codes: NASDAQ-SMALL:ACHV
